脑机路线之争：中企们与马斯克针尖对麦芒

Core Viewpoint - The article discusses the emerging interest in brain-machine interfaces (BMIs) in the capital market, particularly following Elon Musk's provocative ideas about achieving "semi-immortality" through technology [1][2][3]. Industry Overview - The BMI sector has seen a surge, with nearly 50 related companies involved in medical devices, consumer electronics, and content provision, leading to a market capitalization exceeding 1 trillion RMB within just nine trading days in 2026 [1]. - The global BMI market size grew from $1.2 billion in 2019 to nearly $2 billion in 2023, with a compound annual growth rate (CAGR) of over 13% [11]. Company Developments - Musk's Neuralink aims to create a BMI that captures consciousness through invasive methods, while domestic companies like Qiangnao Technology focus on non-invasive techniques, emphasizing safety and rehabilitation [7][10]. - Qiangnao Technology, founded in 2015, has developed the world's first non-invasive brain-controlled bionic hand and has achieved significant market penetration, producing 100,000 units at a fraction of the cost of similar international products [9][10]. Competitive Landscape - The competition between Musk's invasive approach and domestic non-invasive methods represents a broader cultural and technological divergence, with domestic firms prioritizing life preservation and rehabilitation over radical technological replacement [8][11]. - Both Neuralink and Qiangnao Technology are accelerating their efforts, with Neuralink planning large-scale production by 2026 and Qiangnao Technology preparing for an IPO after securing approximately 2 billion RMB in funding [11]. Future Goals - Qiangnao Technology aims to assist 1 million individuals with physical disabilities and improve the lives of 10 million patients suffering from various neurological conditions within the next five to ten years [12].